Company profile for Oneness Biotech

NEW Drugs in Dev.: 8
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Oneness Biotech Co., Ltd. was founded in June 2008. It is a government-approved biotech new pharmaceuticals company that is devoted to the research and development of new drugs. The company was approved by the Securities and Futures Bureau in June 2011 to be traded over the counter and was officially listed and traded for the first time on September 23, 2011. Fountain BioPharma is merged into Oneness Biotech on 23 Aug 2019. O...
Oneness Biotech Co., Ltd. was founded in June 2008. It is a government-approved biotech new pharmaceuticals company that is devoted to the research and development of new drugs. The company was approved by the Securities and Futures Bureau in June 2011 to be traded over the counter and was officially listed and traded for the first time on September 23, 2011. Fountain BioPharma is merged into Oneness Biotech on 23 Aug 2019. Oneness Biotech aims to develop innovative new drugs for global market and its R&D pipeline has been enhanced by acquiring Fountain BioPharma. The current pipeline under development covers drugs under phase I, phase II,

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
1F., No.236, Sec. 4, Xinyi Rd., Da’an Dist., Taipei City 106, Taiwan (R.O.C....
Telephone
Telephone
02-2703-1098
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/sns812-an-innovative-sirna-drug-from-oneness-and-microbio-shanghai-selected-for-ats-2025-oral-presentation-demonstrating-world-leading-clinical-outcomes-in-covid-19-treatment-302457583.html

PR NEWSWIRE
16 May 2025

https://www.prnewswire.com/news-releases/pan-covid-new-drug--sns812-achieves-superiority-in-phase-2-study-302243369.html

PR NEWSWIRE
10 Sep 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty